$8.43
-0.16-1.86%
At close: -
$8.43
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Amicus Therapeutics Stock Guidance | NASDAQ:FOLD | Benzinga
Amicus Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/19/2025 | FOLD | Amicus Therapeutics | FY | 2025 | — | — | — | $618.11M | $655.09M | $636.01M | Get Alert |
| 01/12/2025 | FOLD | Amicus Therapeutics | Q4 | 2024 | — | — | — | $149.90M | $149.90M | $147.53M | Get Alert |
| 01/12/2025 | FOLD | Amicus Therapeutics | FY | 2024 | — | — | — | $528.50M | $528.50M | $526.12M | Get Alert |
| 11/06/2024 | FOLD | Amicus Therapeutics | FY | 2024 | — | — | — | $519.16M | $527.15M | $517.07M | Get Alert |
| 08/08/2024 | FOLD | Amicus Therapeutics | FY | 2024 | — | — | — | $503.19M | $523.16M | $510.32M | Get Alert |
| 05/09/2024 | FOLD | Amicus Therapeutics | FY | 2024 | — | — | — | $499.19M | $519.16M | $529.99M | Get Alert |
| 01/07/2024 | FOLD | Amicus Therapeutics | FY | 2023 | — | — | — | $399.40M | $399.40M | $396.45M | Get Alert |
| 01/09/2023 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $329.00M | $329.00M | $326.68M | Get Alert |
| 08/04/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $355.01M | Get Alert |
| 05/09/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $363.85M | Get Alert |
| 02/24/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $375.35M | Get Alert |
| 01/10/2022 | FOLD | Amicus Therapeutics | Q4 | 2021 | — | — | — | $84.00M | $84.00M | $84.77M | Get Alert |
| 01/10/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $396.55M | Get Alert |
| 01/10/2022 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $306.00M | $306.00M | $308.46M | Get Alert |
| 11/09/2021 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $300.00M | $315.00M | $310.30M | Get Alert |
| 08/05/2021 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $300.00M | $315.00M | $308.54M | Get Alert |
| 05/10/2021 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $300.00M | $315.00M | $312.64M | Get Alert |
| 01/11/2021 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $300.00M | — | $335.44M | Get Alert |
| 01/11/2021 | FOLD | Amicus Therapeutics | Q4 | 2020 | — | — | — | $70.00M | $70.00M | $69.53M | Get Alert |
| 01/11/2021 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $261.00M | $261.00M | $259.24M | Get Alert |
| 11/05/2020 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $250.00M | $260.00M | $256.88M | Get Alert |
| 08/10/2020 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $250.00M | $260.00M | $254.82M | Get Alert |
| 07/17/2020 | FOLD | Amicus Therapeutics | FY | 2020 | — | — | — | $250.00M | $260.00M | $255.22M | Get Alert |
FAQ
What is the most recent guidance for Amicus Therapeutics (FOLD)?
There have been no specific sales or earnings guidance reported for Amicus Therapeutics in recent months.
Browse guidance and forecast on all stocks.